ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2922

Imaging Acquisition Technique Influences Interpretation of Positron Emission Tomography Vascular Activity in Large-Vessel Vasculitis

Kaitlin Quinn1, Joel S. Rosenblum 2, Casey A. Rimland 3, K Bates Gribbons 4, Mark A. Ahlman 5 and Peter C. Grayson 6, 1Georgetown University Hospital/National Institutes of Health, Washington, DC, 2National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, Bethesda, MD, 3National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, Chapel Hill, NC, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 5Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, Bethesda, MD, 6National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health, Bethesda, MD, Bethesda, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: imaging techniques, large vessel vasculitis, positron emission tomography (PET), vasculitis and 18FDG PET/CT scan

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 13, 2019

Title: 6W024: Vasculitis – Non-ANCA-Associated & Related Disorders III: Large Vessel Vasculitis Pathogenesis & Imaging (2918–2923)

Session Type: ACR Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: 18F-flurodeoxyglucose (FDG) positron emission tomography (PET) is one of several imaging modalities used in the assessment of patients with large-vessel vasculitis (LVV).  Conventionally PET images are obtained 1 hour after radiotracer injection; however, delayed imaging may be more sensitive to detect vascular inflammation.   

The objectives of this study were to: 1) determine the impact of imaging acquisition time on interpretation of disease activity on FDG-PET in LVV and 2) assess the relationship between clinical features and image acquisition time.

Methods: An observational cohort of patients with giant cell arteritis (GCA) or Takayasu’s arteritis (TAK) was prospectively recruited.  Patients fulfilled the 1990 ACR Classification Criteria for TAK or modified 1990 ACR Criteria for GCA.  Following injection, whole-body FDG-PET magnetic resonance imaging (MRI) was performed at one-hour uptake time followed by FDG-PET computed tomography (CT) at two-hours uptake time.  A single reader with vascular imaging expertise interpreted the PET studies for evidence of active vasculitis.  Patients were categorized as 1) both time points active (dual active), 2) both time points inactive (dual inactive), 3) only the one-hour time point active (early time point active), and 4) only the two-hour time point active (delayed active). Imaging and clinical assessments were performed blinded to each other within a 24-hour period. 

Agreement was assessed by percent agreement, Cohen’s kappa, and McNemar’s test.  Nominal logistic regression was used to study factors associated with the PET categories, including age, BMI, gender, LVV type, clinical status (active/remission), ESR, CRP, and treatment status (yes/no). Significant variables in the univariable model were included in multivariable regression.

Results: 79 patients (GCA=44, TAK=35) contributed 168 paired one and two-hour PET studies.  A total of 94 out of 168 scans (56%) were interpreted as active at the one-hour time point, and 129 scans (77%) were interpreted as active at the two-hour time point (p< 0.01). Scans were interpreted as both active in 90 cases and both inactive in 35 cases (percent overall agreement=74%, cohen’s kappa=0.45(fair agreement)).  In discordant cases, delayed active only was observed in 39 cases versus early active only in 4 cases (McNemar’s p< 0.01).   

Associations between clinical variables and PET activity categories were also evaluated.  Using multivariable nominal regression, clinically active disease was significantly more common in patients in the delayed active group (Odds Ratio 1.94, 95%CI 1.13 – 3.53; p=0.02) and the dual active group (Odds Ratio 1.71, 95%CI 1.06 – 2.93; p=0.04) compared to the dual inactive group as shown in Table 1.

Conclusion: Imaging protocol significantly influences interpretation of PET activity in LVV.  A substantial proportion of patients with LVV had PET activity only detected by delayed imaging. These patients were significantly more likely to have concomitant clinically-determined active disease.  Imaging acquisition protocols should be standardized in LVV and encourage delayed imaging.


Table i


Disclosure: K. Quinn, None; J. Rosenblum, None; C. Rimland, None; K. Gribbons, None; M. Ahlman, None; P. Grayson, None.

To cite this abstract in AMA style:

Quinn K, Rosenblum J, Rimland C, Gribbons K, Ahlman M, Grayson P. Imaging Acquisition Technique Influences Interpretation of Positron Emission Tomography Vascular Activity in Large-Vessel Vasculitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/imaging-acquisition-technique-influences-interpretation-of-positron-emission-tomography-vascular-activity-in-large-vessel-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/imaging-acquisition-technique-influences-interpretation-of-positron-emission-tomography-vascular-activity-in-large-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology